Venus Remedies Limited share price
NSE: VENUSREM · ISIN INE411B01019
Key numbers
- Market cap
- ₹ 2,233 Cr
- Current price
- ₹ 1,668.40
- 52-week high / low
- ₹ 2,044 / 428
- Stock P/E
- 19.2
- Book value
- ₹ 496.6
- Dividend yield
- 0.60%
- ROCE
- 21.7%
- ROE
- 16.8%
- Debt to equity
- 0.02
- Sales growth (3 yrs)
- 9.9%
- Profit growth (3 yrs)
- 57.0%
- 1-year return
- 286.8%
About Venus Remedies Limited
Venus Remedies Limited engages in the pharmaceutical business in India, Latin America, Europe, the Middle East, Africa, Asia, and internationally. The company is involved in the research and development of solutions focusing on antimicrobial resistance, oncology, skin and wound care, and pain management. It also provides analgesic, analgesic and antipyretic, antibiotic, antidiabetic anticoagulant, antiemetic, antiviral, cardiac, cardiovascular, CNS, disinfectant and antiseptic, gastro therapy, gastro therapy, hepatoprotective, hormones (steroid), immunostimulating agent, iron supplements, mucolytic, muscle relaxant, neurology, respiratory, stress reliver, urology, vitamins, nutrients, minerals, and solvent products, as well as herbal medicine. The company was incorporated in 1989 and is headquartered in Panchkula, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 137 | 193 | 180 | 259 | 179 |
| Operating profit | 15 | 31 | 38 | 63 | 34 |
| Net profit | 10 | 20 | 26 | 47 | 23 |
| EPS (₹) | 7.18 | 15.06 | 19.14 | 35.53 | 17.18 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.